FindTrial
Sign In

A Prospective, Multicenter, Real-world Study Evaluating the Efficacy of Low-intensity Single-wavelength Red Light Therapy in Controlling Myopia in Adolescents

Low-intensity Single-wavelength Red Light Therapy for Adolescent Myopia: A Prospective, Multicenter, Real-world Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300076896
Enrollment
Unknown
Registered
2023-10-24
Start date
2020-07-01
Completion date
Unknown
Last updated
2023-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Interventions

Treatment group:Use the low-intensity single-wavelength red light therapy

Sponsors

Zhongshan Ophthalmic Center, Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
4 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1) Adolescents aged 4-18 years old 2) Confirmed myopia: Post-ciliary muscle paralysis, both eyes have a spherical equivalent of -1.0D or higher 3) Including those who have used or are currently using myopia control treatments, such as orthokeratology lenses, low-concentration atropine, myopia prevention glasses, soft corneal contact lens, etc., all are eligible 4) Participants have the willingness to undergo treatment

Exclusion criteria

Exclusion criteria: 1)Presence of strabismus or other binocular vision abnormalities 2)Presence of other ocular and systemic abnormalities 3)Other reasons deemed by the research doctor as unsuitable for inclusion in the project

Design outcomes

Primary

MeasureTime frame
Axial length, AL, mm;—

Secondary

MeasureTime frame
Spherical equivalent, SE, D;Uncorrected visual acuity, UCVA;Best corrected visual acuity, BCVA;—

Countries

China

Contacts

Public ContactJunwen Zeng

Zhongshan Ophthalmic Center, Sun Yat-sen University

zeng_zoc@163.com+86 136 0286 0456

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026